Humana Stock

What is Humana stock (HUM)?

Humana stock is the publicly traded common equity of Humana Inc., one of the largest health insurance companies in the United States. The shares trade under the ticker symbol HUM on the New York Stock Exchange (NYSE). As a large-cap health insurer, Humana is a widely followed name and has been included in major U.S. market indices that track big, established companies. When investors, analysts, or news outlets discuss "HUM," they are referring to these NYSE-listed shares. Owning the stock means owning a small fractional stake in the company, and its price rises and falls continuously with market demand. Because Humana operates in the closely watched Medicare and health-benefits space, its stock tends to draw attention from investors interested in healthcare and government-related coverage trends. This page is a plain-language reference only.

Where to check the Humana stock price

We intentionally do not print a live or "latest" price, because any number here would be stale the moment the market moved. Instead, use one of the sources below to see accurate, up-to-date figures for HUM. Each gives you something slightly different, from a fast quote to the underlying official filings.

For anything tied to your own money — placing an order, checking a real-time quote, or confirming a dividend — rely on your brokerage or the official Humana investor relations resources rather than a summary page like this one.

How is Humana’s business structured?

Understanding a stock starts with understanding the business behind it. At a high level, Humana earns most of its revenue from health plans, with Medicare Advantage being the centerpiece — the private Medicare plans it offers to older adults and some people with disabilities. Alongside these insurance products, Humana runs healthcare services under its CenterWell brand, which includes primary care, pharmacy, and home-health operations that serve members directly.

In broad terms, that means the company sits at the intersection of insurance and care delivery: it collects premiums to provide coverage and also operates clinics and services that treat patients. Because Medicare is a government program, policy and reimbursement decisions can meaningfully affect the business, which is one reason the stock is closely watched. We deliberately avoid quoting revenue splits or financial figures here; for the exact segment breakdown, read Humana’s official filings and investor materials.

Why does business structure matter to someone looking at the stock? A company whose results depend heavily on one program tends to move with news about that program, so a reader following HUM will often see the share price react to Medicare headlines, enrollment trends, and annual plan-rating updates. None of that tells you what the stock will do next — it simply explains the kinds of factors that investors and analysts weigh when they study the company. The company’s own filings describe these risks in detail, and reading them directly is far more reliable than relying on any short summary.

Things investors commonly research

If you are getting up to speed on HUM, the topics below are frequent starting points. These are framed as things to look up on primary sources — not recommendations, and not signals to buy or sell.

A useful habit is to trace every claim back to a primary source — a filing, an official release, or a regulator’s notice — rather than relying on secondhand summaries, including this one.

Not investment advice